Media & Announcements
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
26th International Scientific Conference on Expert Education Programs.
Polpharma joins the 26th International Scientific Conference on Expert Education Programs (EPE2026), supporting expert-led pharmaceutical education.
Group News
June 1, 2026
Polish RNA Technology Platform
Polpharma opens Poland's only end-to-end RNA medicine development platform in Starogard Gdanski, a PLN 238.7m investment strengthening medicine security.
Science & Innovation
May 20, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Group News
Polpharma API
ZF Polpharma
July 19, 2022
Polpharma partners with Pikralida biopharmaceutical start-up
Polpharma partners with start-up Pikralida to make the PKL-021 drug substance under GMP for preclinical work and a phase one epilepsy-prevention trial.
Corporate Social Responsibility
ZF Polpharma
June 6, 2022
Polpharma’s Compliance Team awarded by the Compliance Institute
The Compliance Institute honours Polpharma's Compliance Team in its Compliance Awards, recognising achievements in compliance management and whistleblowing.
Corporate Social Responsibility
ZF Polpharma
June 6, 2022
Polpharma received another CSR Golden Leaf
Polpharma wins POLITYKA's CSR Golden Leaf for the eighth time, with its ISO 26000-based practices verified by independent auditor Deloitte Polska.
Corporate Social Responsibility
Polpharma Group
May 25, 2022
Drug donations support for Ukraine
Polpharma's drug donations to Ukraine exceed one million packages, including antibiotics, cardiological drugs, anaesthetics and paediatric medicines.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY